Opthea News

Watching Protara Therapeutics, Opthea Ltd.; Shares Moving Higher As Traders Circulate Post From 'TipRanks' Suggesting "These 2 'Strong Buy' Penny Stocks Could Surge Over 400%, Says Oppenheimer"

Watching Protara Therapeutics, Opthea Ltd.; Shares Moving Higher As Traders Circulate Post From 'TipRanks' Suggesting "These 2 'Strong Buy' Penny Stocks Could Surge Over 400%, Says Oppenheimer"

BenzingaMay 9 22:24

Opthea Announces Upcoming Presentations at the Retina World Congress 2024

MELBOURNE, Australia and PRINCETON, N.J., May 01, 2024 (GLOBE NEWSWIRE) -- Opthea Limited (NASDAQ:OPT, the "Company")), a clinical-stage biopharmaceutical company developing novel therapies to treat highly prevalent

GlobeNewswireMay 1 19:30

Opthea Showcases Retinal Disease Therapy Advances

TipRanksMay 1 09:57

Opthea Advances Pivotal Trials for Eye Disease Drug

TipRanksApr 30 07:57

Opthea to Present at the OIS Retina Innovation Summit at ARVO

MELBOURNE, Australia and PRINCETON, N.J., April 25, 2024 (GLOBE NEWSWIRE) -- Opthea Limited (NASDAQ:OPT, the "Company")), a clinical-stage biopharmaceutical company developing novel therapies to treat highly prevalent

GlobeNewswireApr 25 21:00

Opthea Limited Issues New Contractor Options

TipRanksApr 15 11:17

Owning 39% Shares,institutional Owners Seem Interested in Opthea Limited (ASX:OPT),

Yahoo FinanceApr 13 04:49

Opthea Hires New VP to Advance Retinal Therapies

TipRanksApr 9 06:57

Opthea Appoints John Han, PharmD, as VP Medical Affairs

MELBOURNE, Australia and PRINCETON, N.J., April 08, 2024 (GLOBE NEWSWIRE) -- Opthea Limited (NASDAQ:OPT, the "Company")), a clinical-stage biopharmaceutical company developing novel therapies to treat highly prevalent

GlobeNewswireApr 9 06:42

Analysts Offer Insights on Healthcare Companies: Universal Health (UHS), Ultragenyx Pharmaceutical (RARE) and Opthea Limited Sponsored ADR (OPT)

TipRanksApr 8 15:40

Opthea Limited Foresees Visionary Breakthroughs

TipRanksApr 5 07:37

Opthea to Participate in the 23?? Annual Needham Virtual Healthcare Conference

Globe NewswireApr 5 06:34

Opthea Limited Announces Director's Resignation and Final Interests

TipRanksApr 4 15:57

Opthea Limited Welcomes New Director

TipRanksApr 4 15:27

Why A2 Milk, Lindsay Australia, Meridian Energy, and Opthea Shares Are Falling Today

The Motley FoolApr 4 10:19

Opthea Bolsters Board With Biopharmaceutical Expertise

TipRanksApr 4 10:07

Opthea Limited Foresees Growth in Vision Therapy

TipRanksApr 4 06:07

Press Release: Opthea Appoints Sujal Shah to the Board of Directors

Opthea Appoints Sujal Shah to the Board of Directors Former CymaBay Therapeutics CEO brings extensive leadership experience to his role as a Non-Executive Director and Audit and Risk Committee Chair

Dow JonesApr 4 05:39

Opthea to Host Key Opinion Leader Event on Sozinibercept (OPT-302) in Wet Age-Related Macular Degeneration on April 3, 2024

MELBOURNE, Australia and PRINCETON, N.J., March 19, 2024 (GLOBE NEWSWIRE) -- Opthea Limited ((ASX:OPT, NASDAQ:OPT, "Opthea")), a clinical-stage biopharmaceutical company developing novel therapies to treat highly

GlobeNewswireMar 19 18:00

Opthea to Participate in the Leerink Partners Global Biopharma Conference

MELBOURNE, Australia, March 05, 2024 (GLOBE NEWSWIRE) -- Opthea Limited (ASX:OPT; NASDAQ:OPT; "Opthea"), a clinical-stage biopharmaceutical company developing novel therapies to treat highly prevale

GlobeNewswireMar 6 06:08